HomeTELO • NASDAQ
add
Telomir Pharmaceuticals Inc
Previous close
$1.26
Day range
$1.21 - $1.26
Year range
$1.05 - $4.06
Market cap
42.98M USD
Avg Volume
85.83K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.13M | -26.53% |
Net income | -2.06M | 28.88% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 7.29M | 475.51% |
Total assets | 7.34M | 454.48% |
Total liabilities | 1.43M | 109.70% |
Total equity | 5.91M | — |
Shares outstanding | 34.38M | — |
Price to book | 7.41 | — |
Return on assets | -72.39% | — |
Return on capital | -79.30% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -2.06M | 28.88% |
Cash from operations | -1.20M | -98.30% |
Cash from investing | — | — |
Cash from financing | 1.16M | 11.71% |
Net change in cash | -42.63K | -109.88% |
Free cash flow | -699.13K | -246.67% |
About
Founded
2021
Headquarters
Website
Employees
5
